{
  "url": "https://en.wikipedia.org/wiki/Boehringer_Ingelheim",
  "title": "Boehringer Ingelheim",
  "header": [
    [
      [
        "Drug Name"
      ],
      [
        null
      ]
    ],
    [
      [
        "Description"
      ],
      [
        null
      ]
    ],
    [
      [
        "Potential Indication"
      ],
      [
        null
      ]
    ],
    [
      [
        "Testing Phase"
      ],
      [
        null
      ]
    ]
  ],
  "data": [
    [
      [
        [
          "Olodaterol"
        ],
        [
          "/wiki/Olodaterol"
        ]
      ],
      [
        [
          "Long-acting beta-agonist"
        ],
        [
          "/wiki/Long-acting_beta-agonist"
        ]
      ],
      [
        [
          "Chronic obstructive pulmonary disease"
        ],
        [
          "/wiki/Chronic_obstructive_pulmonary_disease"
        ]
      ],
      [
        [
          "Approved"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Tiotropium"
        ],
        [
          "/wiki/Tiotropium"
        ]
      ],
      [
        [
          "Long acting muscarinic antagonist"
        ],
        [
          null
        ]
      ],
      [
        [
          "Cystic fibrosis",
          "asthma",
          "chronic obstructive pulmonary disease"
        ],
        [
          "/wiki/Cystic_fibrosis",
          "/wiki/Asthma",
          "/wiki/Chronic_obstructive_pulmonary_disease"
        ]
      ],
      [
        [
          "Approved"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Nintedanib"
        ],
        [
          "/wiki/Nintedanib"
        ]
      ],
      [
        [
          "VEGFR",
          "FGFR",
          "PDGFR"
        ],
        [
          "/wiki/VEGFR",
          "/wiki/FGFR",
          "/wiki/PDGFR"
        ]
      ],
      [
        [
          "Idiopathic pulmonary fibrosis",
          "non-small cell lung cancer",
          "ovarian cancer"
        ],
        [
          "/wiki/Idiopathic_pulmonary_fibrosis",
          "/wiki/Non-small_cell_lung_cancer",
          "/wiki/Ovarian_cancer"
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Afatinib"
        ],
        [
          "/wiki/Afatinib"
        ]
      ],
      [
        [
          "ErbB"
        ],
        [
          "/wiki/ErbB"
        ]
      ],
      [
        [
          "Breast cancer",
          "head and neck cancer",
          "non-small cell lung cancer"
        ],
        [
          "/wiki/Breast_cancer",
          "/wiki/Head_and_neck_cancer",
          "/wiki/Non-small_cell_lung_cancer"
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Volasertib"
        ],
        [
          "/wiki/Volasertib"
        ]
      ],
      [
        [
          "PLK1"
        ],
        [
          "/wiki/PLK1"
        ]
      ],
      [
        [
          "Various cancer types"
        ],
        [
          null
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Deleobuvir"
        ],
        [
          "/wiki/Deleobuvir"
        ]
      ],
      [
        [
          "NS5B"
        ],
        [
          "/wiki/NS5B"
        ]
      ],
      [
        [
          "Hepatitis C"
        ],
        [
          "/wiki/Hepatitis_C"
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Faldaprevir"
        ],
        [
          "/wiki/Faldaprevir"
        ]
      ],
      [
        [
          "NS3",
          "4A"
        ],
        [
          "/wiki/NS3_(HCV)",
          "/wiki/NS4A"
        ]
      ],
      [
        [
          "Hepatitis C"
        ],
        [
          "/wiki/Hepatitis_C"
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Empagliflozin"
        ],
        [
          "/wiki/Empagliflozin"
        ]
      ],
      [
        [
          "SGLT-2"
        ],
        [
          "/wiki/SGLT-2"
        ]
      ],
      [
        [
          "Diabetes mellitus type II"
        ],
        [
          "/wiki/Diabetes_mellitus_type_II"
        ]
      ],
      [
        [
          "Approved"
        ],
        [
          null
        ]
      ]
    ],
    [
      [
        [
          "Idarucizumab"
        ],
        [
          "/wiki/Idarucizumab"
        ]
      ],
      [
        [
          "dabigatran"
        ],
        [
          "/wiki/Dabigatran"
        ]
      ],
      [
        [
          "anticoagulation"
        ],
        [
          "/wiki/Anticoagulation"
        ]
      ],
      [
        [
          "Phase III"
        ],
        [
          null
        ]
      ]
    ]
  ],
  "context": "",
  "idx": 12692
}